KiraGen Bio is proud to announce that Ryan Murray , our Co-Founder and Chief Scientific Officer, has published his PhD thesis research in Nature Communications , one of the world’s leading scientific journals. The study demonstrates that solid tumors suppress T cell function through multiple, overlapping, and non-redundant mechanisms rather than any single dominant pathway. This coordinated suppression helps explain why many single-target approaches have struggled to achieve

KiraGen Bio is honored to announce an investment from the Yuvaan Tiwari Foundation , a leading advocate for breakthrough research in diffuse midline glioma (DMG), DIPG, and other fatal pediatric brain cancers. The Foundation was established by Parvati and Satya Tiwari in memory of their son Yuvaan, who was diagnosed with DMG at age two and passed away at three after a courageous seven-month fight. Yuvi loved sunshine and the color yellow, and even on the grayest days, he woul

We’re thrilled to share that KiraGen Bio has been selected to join the inaugural cohort of the new AI BioHub , a bold initiative from...